GSK (BSP:G1SK34) Ending Cash Position : R$16,376 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is GSK Ending Cash Position?

GSK's Ending Cash Position for the quarter that ended in Mar. 2024 was R$16,376 Mil.

GSK's quarterly Ending Cash Position declined from Sep. 2023 (R$18,459 Mil) to Dec. 2023 (R$17,726 Mil) and declined from Dec. 2023 (R$17,726 Mil) to Mar. 2024 (R$16,376 Mil).

GSK's annual Ending Cash Position declined from Dec. 2021 (R$28,718 Mil) to Dec. 2022 (R$21,882 Mil) and declined from Dec. 2022 (R$21,882 Mil) to Dec. 2023 (R$17,726 Mil).

GSK Ending Cash Position Historical Data

The historical data trend for GSK's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Ending Cash Position Chart

GSK Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

25,987.99

36,386.31

28,718.17

21,882.45

17,726.11

GSK Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															17,199.76	18,618.11	18,459.00	17,726.11	16,375.76

GSK Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

GSK's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	21242.804	+	-3516.692
	=	17,726

GSK's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	18084.203	+	-1708.444
	=	16,376

GSK Ending Cash Position Related Terms

Thank you for viewing the detailed overview of GSK's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK (BSP:G1SK34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (BSP:G1SK34) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

GLAXF:USA GSK:USA GSK N:Mexico GSKl:UK GSK:UK GS71:Germany GSK:Argentina

Address

980 Great West Road, Brentford, Middlesex, GBR, TW8 9GS

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK (BSP:G1SK34) Headlines

No Headlines